Rheumatic Diseases and Treatment Journal emphasize in publishing the original scholarly articles related to Rheumatic Disorders and Treatment worldwide. The journal follows rapi"> Rheumatic Diseases and Treatment Journal is an open access journal maintained by Edelweiss publications. The Journal emphasize in publishing the original scholarly articles related to Rheumatic Diseases and Treatment Journal worldwide.
Bone to death due to loss of blood flow to bone tissue is known as osteonecrosis. Hip, knees, shoulders, and ankles are mostly affected by this disease. Serious trauma, consuming high dosage of corticosteroid medications like prednisone, cortisone or methylprednisolone, excess alcohol consumption, systemic lupus erythematosus are causes of osteonecrosis. Pain, redness of the skin, swelling, blisters, fluid collection, skin discolouration, sensation and numbness are some common symptoms of the disease.
Chemical changes in the bone marrow in the earliest stages can show osteonecrosis; this can be diagnosed by MRI. Pain medications, limiting weight-bearing and surgery are treatments for osteonecrosis. Nonsteroidal Anti-Inflammatory Drugs or NSAIDs are used in the treatment of osteonecrosis by reducing inflammation in the soft tissues surrounding the joint. Stomach upset, ulcers and side effects may affect due to long term usage of NSAIDs.
Edelweiss publications include rigorous peer review process and high scientific publishing standard to ensure superior contribution to scholarly literature added with high quality production. Rheumatic Diseases and Treatment Journal of rheumatology aims to publish scientific research related to rheumatic diseases and treatment in the form of Research/Review/Case Report/short commentaries/Mini Reviews.